Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Crispr Therapeutics Ag (NQ: CRSP ) 45.92 -0.87 (-1.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 970,991 Open 46.72 Bid (Size) 46.10 (1) Ask (Size) 46.65 (5) Prev. Close 46.79 Today's Range 45.87 - 47.36 52wk Range 37.55 - 91.10 Shares Outstanding 78,935,098 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Dirt Cheap Stocks to Buy Right Now September 21, 2024 Bargain hunters should love these great stocks. Via The Motley Fool Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? September 19, 2024 There's a lot of growth on the way, and soon. Via The Motley Fool Performance YTD -30.49% -30.49% 1 Month -6.61% -6.61% 3 Month -17.93% -17.93% 6 Month -35.30% -35.30% 1 Year +0.13% +0.13% More News Read More 1 Biotech Stock Down 62% to Buy and Hold September 12, 2024 Via The Motley Fool 3 No-Brainer Biotech Stocks to Buy With $200 Right Now September 12, 2024 Via The Motley Fool Looking for Stock Bargains With Room to Run? Try This. September 11, 2024 Via The Motley Fool Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal? September 05, 2024 Via The Motley Fool 3 Monster Biotech Stocks to Buy Before 2025 September 02, 2024 Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 August 26, 2024 Via The Motley Fool Got the Market Sell-Off Blues? Do These 3 Things Right Now August 11, 2024 Via The Motley Fool Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom August 08, 2024 Via Benzinga 7 Biotech Stocks to Buy for Their Game-Changing Potential August 08, 2024 Via InvestorPlace The 3 Best Gene Editing Stocks to Buy in August 2024 August 07, 2024 Via InvestorPlace Is It Too Late to Buy Vertex Pharmaceuticals Stock? August 06, 2024 Via The Motley Fool CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024 August 05, 2024 Via InvestorPlace Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 August 05, 2024 Via The Motley Fool Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker August 04, 2024 Via The Motley Fool 3 Unstoppable Stocks to Buy in August August 03, 2024 Via The Motley Fool 10 Best Small and Mid-Cap Stocks to Consider Buying in August August 01, 2024 Via The Motley Fool Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought July 31, 2024 Via The Motley Fool The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 July 29, 2024 Via InvestorPlace 3 Small-Cap Stocks to Buy at a 52-Week Low July 27, 2024 Via InvestorPlace 3 Gene Editing Stocks Shaping the Future of Medicine July 22, 2024 Via InvestorPlace 3 Monster Stocks in the Making to Buy Right Now July 20, 2024 Via The Motley Fool 3 Gene Editing Stocks That Could Grow Your Wealth July 17, 2024 Via InvestorPlace 3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition July 17, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.